DK324385A - Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof - Google Patents

Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof Download PDF

Info

Publication number
DK324385A
DK324385A DK324385A DK324385A DK324385A DK 324385 A DK324385 A DK 324385A DK 324385 A DK324385 A DK 324385A DK 324385 A DK324385 A DK 324385A DK 324385 A DK324385 A DK 324385A
Authority
DK
Denmark
Prior art keywords
active substance
controlled release
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
DK324385A
Other languages
English (en)
Other versions
DK324385D0 (da
Inventor
Yegnaswami Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of DK324385D0 publication Critical patent/DK324385D0/da
Publication of DK324385A publication Critical patent/DK324385A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK324385A 1984-07-18 1985-07-17 Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof DK324385A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63197984A 1984-07-18 1984-07-18

Publications (2)

Publication Number Publication Date
DK324385D0 DK324385D0 (da) 1985-07-17
DK324385A true DK324385A (da) 1986-01-19

Family

ID=24533574

Family Applications (1)

Application Number Title Priority Date Filing Date
DK324385A DK324385A (da) 1984-07-18 1985-07-17 Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof

Country Status (11)

Country Link
EP (1) EP0171528A3 (da)
JP (1) JPH0649645B2 (da)
KR (1) KR920007568B1 (da)
AU (1) AU571659B2 (da)
CA (1) CA1236023A (da)
DK (1) DK324385A (da)
FI (1) FI852804A7 (da)
NO (1) NO852880L (da)
NZ (1) NZ211449A (da)
PH (1) PH20391A (da)
ZA (1) ZA853462B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003197A1 (en) * 1985-11-29 1987-06-04 Fisons Plc Pharmaceutical composition including sodium cromoglycate
US4859462A (en) * 1986-07-30 1989-08-22 Fisons Corporation Polymer-treated ion exchange resins
NZ219925A (en) * 1986-07-30 1989-06-28 Pennwalt Corp Polymer-treated sulphonic acid cationic exchange resin particles
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
US4859461A (en) * 1986-07-30 1989-08-22 Fisons Corporation Coatable ion exchange resins
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5186930A (en) * 1988-11-14 1993-02-16 Schering Corporation Sustained release oral suspensions
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof
IT1241417B (it) 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
JP3286315B2 (ja) * 1990-06-20 2002-05-27 アドバンスト ポリマー システムズ,インコーポレイティド 可溶性活性物質の調節された放出のための組成物及び方法
HUT74642A (en) * 1990-12-21 1997-01-28 Richardson Vicks Inc Polyamine drug-resin complex
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
JP4808405B2 (ja) 2002-11-26 2011-11-02 ホ−レンベック ギャリ− ア−ル 高度に水溶性の電解質薬剤のための水性徐放性ドラッグデリバリーシステム
WO2006135362A1 (en) * 2005-06-09 2006-12-21 Upm Pharmaceuticals, Inc. Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
WO2010115015A1 (en) * 2009-04-03 2010-10-07 Coating Place, Inc. Modified-release pharmaceutical drug composition
ES2470940B1 (es) * 2012-12-21 2015-04-16 Laboratorios Rubió, S.A. Aducto entre un poliol y una resina de intercambio iónico
ES2471340B1 (es) 2012-12-21 2015-08-17 Laboratorios Rubió, S.A. Composición farmacéutica oral para fármacos de elevada posología

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
BE861141A (fr) * 1976-11-26 1978-03-16 Pennwalt Corp Preparations pharmaceutiques a liberation soutenue des substances actives
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations

Also Published As

Publication number Publication date
AU571659B2 (en) 1988-04-21
AU3963585A (en) 1986-01-23
JPS6130514A (ja) 1986-02-12
EP0171528A2 (en) 1986-02-19
EP0171528A3 (en) 1986-04-23
JPH0649645B2 (ja) 1994-06-29
FI852804L (fi) 1986-01-19
FI852804A7 (fi) 1986-01-19
FI852804A0 (fi) 1985-07-17
CA1236023A (en) 1988-05-03
KR920007568B1 (ko) 1992-09-07
NO852880L (no) 1986-01-20
DK324385D0 (da) 1985-07-17
PH20391A (en) 1986-12-10
KR860000865A (ko) 1986-02-20
NZ211449A (en) 1987-08-31
ZA853462B (en) 1985-12-24

Similar Documents

Publication Publication Date Title
DK324385D0 (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
DK158032C (da) Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat
DK494782A (da) Kapsel med langvarig frigoerelse af aktivt stof til droevtyggere
DK178285D0 (da) Catecholamin-holdig intranasal laegemiddelformulering med forsinket frigivelse af den aktive bestanddel
DK158770C (da) Anvendelse af paroxetin til fremstilling af medikament mod fedme
NO862956L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.
DK272383A (da) Farmaceutisk blandingspraeparat med kontrolleret frigivelse af aktivt stof indbefattet maskering af daarlig smag og foroegelse af det aktive stofs stabilitet
DK147386D0 (da) Derivater af methylen-bisphosphonsyre, fremgangsmaade til fremstillingaf samme samt farmaceutisk sammensaetning
DK386986A (da) Injicerbar halvfast farmaceutisk formulering med langsom frigivelse af den aktive bestanddel
DK106685A (da) Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf
DK165984C (da) Fremgangsmaade til fremstilling af sphingosinderivater
DK524489D0 (da) Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer
DK38493A (da) Fremgangsmaade til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
DK516286D0 (da) Fremgangsmaade til fremstilling af oxazolderivater
DK414180A (da) Fremgangsmaade til fremstilling af dibenzazepinderivater
DK115291A (da) Fremgangsmaade til fremstilling af amfotere overfladeaktive imidazolinderivater
DK464686D0 (da) Praeparat med kontrolleret afgivelse af det aktive stof
DK158224C (da) Fremgangsmaade til fremstilling af indolderivater
DK163980A (da) Fremgangsmaade til fremstilling af et biologisk aktivt stof 41.200rp med immunstimulerende virkning
DK206985A (da) Transdermal doseringsform med forbedret gennemtraengning af det aktive stof
DK258886A (da) Fremgangsmaade til fremstilling af alkyloxiraner
DK509986D0 (da) Fremgangsmaade til fremstilling af aryl-cyanamider
LV5394A3 (lv) Panemiens arstniecibas lidzekla iegusanai ar regulejamu aktivas vielas izdalisanos
DK163830C (da) Fremgangsmaade til fremstilling af riboflavin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment